Testicular cancer is rare, affecting roughly 1 in 250 men during their lifetime
Testicular cancer accounts for about 1 to 2 percent of all cancers in men. In the United States, doctors diagnose approximately 9,000 to 10,000 new cases each year. While that number sounds substantial in absolute terms, it means the lifetime risk for any individual man is low—around 0.4 percent, or about 1 in 250.
The rarity of testicular cancer is one reason many men do not think about it as a health concern. Yet it remains the most common cancer in men aged 15 to 35, which shifts the picture for younger men specifically. For that age group, testicular cancer is far more likely than prostate cancer, lung cancer, or colorectal cancer.
Key Takeaways
- Testicular cancer affects roughly 1 in 250 men over a lifetime, making it uncommon overall but the most frequent cancer in men aged 15 to 35.
- About 9,000 to 10,000 new cases are diagnosed each year in the United States, with incidence varying slightly by race and ethnicity.
- Survival rates are high when caught early—over 95 percent five-year survival overall—because testicular cancer often appears as a noticeable lump.
- Risk increases with a family history of testicular cancer or a personal history in the other testicle, but most men with the disease have no known risk factors.
- Incidence has risen modestly over recent decades, though the reason remains unclear and may involve detection, reporting, or environmental factors.
Age groups with the highest risk
Testicular cancer peaks in men between ages 20 and 40, with the median age at diagnosis around 33. This makes it distinctly different from most other male cancers, which become more common with age. A man in his 20s is more likely to be diagnosed with testicular cancer than a man in his 60s.
The disease does occur outside this age range. It can appear in adolescents and in men over 50, but these cases are less frequent. Germ cell tumors, the most common type of testicular cancer, follow this age pattern most closely. Lymphomas and other types that develop in the testicle tend to occur in older men.
How incidence varies by race and ethnicity
Testicular cancer rates differ across racial and ethnic groups in the United States. White men have the highest incidence, followed by Hispanic men, Black men, and Asian or Pacific Islander men. The reasons for these differences are not fully understood and likely involve a mix of genetic, environmental, and healthcare access factors.
These variations appear in multiple cancer registries and have been documented over decades. The gap between the highest and lowest incidence groups is meaningful but not extreme—roughly a factor of two to three. Importantly, survival rates after diagnosis do not differ substantially by race when access to treatment is equal, suggesting that differences in incidence reflect true biological or environmental variation rather than detection bias alone.
How testicular cancer incidence has changed over time
Testicular cancer incidence has risen slowly but steadily over the past 40 to 50 years in developed countries, including the United States. The increase is modest—roughly 0.5 to 1 percent per year—but consistent. This trend appears across multiple countries and racial groups, which suggests a real change rather than a reporting artifact.
The cause of this increase remains unknown. Researchers have investigated environmental exposures, reproductive patterns, obesity, and other factors, but no single explanation accounts for the rise. Some of the increase may reflect better detection or more complete reporting, but the trend appears too large to be explained by detection alone. The increase has not accelerated in recent years, and rates have stabilized in some populations.
Why survival rates are high despite the disease being serious
Testicular cancer has one of the highest survival rates of any cancer type. The five-year survival rate is over 95 percent overall, and for cancers caught before they spread beyond the testicle, survival exceeds 99 percent. Even when the disease has spread to lymph nodes or distant sites at diagnosis, survival rates remain substantially higher than for many other cancers.
Several factors explain this. Testicular cancer often produces a noticeable lump or swelling that men can detect themselves, allowing diagnosis at an earlier stage. The disease responds well to chemotherapy, radiation, and surgery—treatments that have improved significantly over the past 30 years. Tumor markers in the blood (alpha-fetoprotein and human chorionic gonadotropin) allow doctors to track treatment response and detect recurrence early. These advantages combine to make testicular cancer one of the most treatable cancers, even when diagnosed at an advanced stage.
Risk factors that increase the chance of testicular cancer
A personal or family history of testicular cancer is the strongest known risk factor. Men who have had cancer in one testicle face a 3 to 5 percent risk of developing it in the other testicle over their lifetime. Men whose father or brother had testicular cancer have a modestly increased risk, though the absolute increase is small.
Undescended testicles (cryptorchidism) at birth or in early childhood raise the risk, even if the testicle is surgically corrected later. Men with a history of infertility or poor sperm production also show higher rates of testicular cancer, though whether infertility causes cancer or both reflect a shared underlying condition remains unclear. Certain genetic syndromes and conditions affecting sexual development increase risk. Despite these known factors, most men diagnosed with testicular cancer have no identifiable risk factor, meaning the disease can occur in men with no family history or prior warning signs.
Geographic and international patterns
Testicular cancer incidence varies significantly across countries. Rates are highest in Northern Europe and Australia, intermediate in North America, and lower in Asia, Africa, and Latin America. These geographic patterns have remained relatively stable over decades, suggesting that underlying population characteristics—genetic, environmental, or behavioral—differ between regions.
Migration studies show that men who move from low-incidence to high-incidence countries gradually develop rates closer to their new country, though the shift is not complete. This suggests that both inherited factors and environmental or lifestyle factors contribute to the geographic variation. The specific environmental or lifestyle factors responsible have not been identified with certainty.
Frequently Asked Questions
Is testicular cancer becoming more common?
Yes, incidence has risen slowly over the past 40 to 50 years in developed countries, at a rate of roughly 0.5 to 1 percent per year. The cause is not known. Some of the increase may reflect better detection or more complete reporting, but the trend appears too large to be explained by detection alone.
What are my chances of getting testicular cancer?
The lifetime risk for any man is roughly 1 in 250, or about 0.4 percent. If you are between ages 20 and 40, your risk is higher than the average man, since that age group accounts for most diagnoses. A family history or prior cancer in the other testicle raises your individual risk.
Why is testicular cancer so common in young men compared to other cancers?
Testicular cancer arises from germ cells, which are particularly active and prone to malignant change during young adulthood. Most other cancers develop from accumulated mutations over decades, which is why they become more common with age. The biology of germ cell tumors makes them a disease of younger men.
Does race affect my risk of testicular cancer?
Incidence varies by race and ethnicity, with white men having the highest rates and Asian or Pacific Islander men having the lowest. The reasons for these differences are not fully understood. Survival rates after diagnosis do not differ substantially by race when access to treatment is equal.
If my father had testicular cancer, what is my risk?
Your risk is higher than average, but still relatively low in absolute terms. Men with a family history of testicular cancer have roughly a 3 to 5 percent lifetime risk, compared to 0.4 percent for men without a family history. Discuss screening and self-examination with your doctor.